v3.25.1

Available-for-Sale Securities

12 Months Ended

Dec. 31, 2024

Investments, Debt and Equity Securities [Abstract]

Available-for-Sale Securities

5. Available-for-Sale Securities

The following table summarizes the Company's available-for-sale securities as of December 31, 2024 and December 31, 2023 (in thousands).

		December 31, 2024
						Unrealized
Short-term investments		Amortized Cost				Gains				Losses				Estimated Fair Value
U.S. Treasury Bills		$	36,110			$	11			$	—			$	36,121
Total available-for-sale securities		$	36,110			$	11			$	—			$	36,121

		December 31, 2023
						Unrealized
Cash equivalents		Amortized Cost				Gains				Losses				Estimated Fair Value
U.S. Treasury Bills		$	25,160			$	4			$	—			$	25,164
Total available-for-sale securities		$	25,160			$	4			$	—			$	25,164

X

- References

No definition available.

+ Details

Name:	us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for cash, cash equivalents, investments in debt and equity instruments (including cost and equity investees and related income statement amounts), equity and cost method investments, investments in joint ventures and any other investment.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 13
-Subparagraph (d)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482477/820-10-65-13

+ Details

Name:	us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration